FDA Panel Recommends Merck Covid Pill, Despite ‘More Questions Than Answers’
The U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee on Tuesday voted narrowly, 13 to 10, to recommend Emergency Use Authorization (EUA) of Merck’s five-day pill to treat COVID. The drug, molnupiravir, sold under the brand name Lagevrio and developed with Ridgeback …
Read More